Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Enoxaparin-sodium

Gastrointestinal bleed: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Reed-Guy L, et al. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study. Neuro-Oncology 24: 2172-2179, No. 12, Dec 2022. Available from: URL: http://doi.org/10.1093/neuonc/noac125 Reed-Guy L, et al. Risk of intracranial hemorrhage with direct oral anticoagulants vs low molecular weight heparin in glioblastoma: A retrospective cohort study. Neuro-Oncology 24: 2172-2179, No. 12, Dec 2022. Available from: URL: http://​doi.​org/​10.​1093/​neuonc/​noac125
Metadaten
Titel
Enoxaparin-sodium
Gastrointestinal bleed: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41440-7

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Chlorhexidine

Case report

Favipiravir

Case report

Allopurinol

Case report

Succimer